The National Institute for Health and Care Excellence is advising healthcare professionals to restrict use of antibiotics for chronic obstructive pulmonary disease (COPD).In new guidelines, the Institute recommends that the risk of antimicrobial resistance should […]
Bristol-Myers Squibb (BMS) has announced that the European Commission (EC) has expanded the indication for Sprycel (dasatinib) to include the treatment of children and adolescents aged 1 year to 18 years with Philadelphia chromosome-positive (Ph+) […]
Herantis Pharma has initiated a non-invasive CDNF development program to broaden the application of CDNF in Parkinson’s disease and potentially other neurodegenerative disorders.In conjunction, Herantis and the University of Helsinki have signed a licensing agreement […]
Finnish pharmaceutical company Orion has recruited the first patients in a phase 3 clinical trial, dubbed REFALS, to evaluate orally administered levosimendan (ODM-109) for the treatment of symptoms of amyotrophic lateral sclerosis (ALS).The purpose of […]
UK and Irish regulatory authorities have recalled all batches of valsartan containing drugs manufactured by Dexcel Pharma and Accord Healthcare, previously known as Actavis Group.Therapeutics containing valsartan as the active ingredient are commonly used for […]